Clamoxyl Long Acting 150 mg/ml Suspension for Injection

Riik: Suurbritannia

keel: inglise

Allikas: VMD (Veterinary Medicines Directorate)

Osta kohe

Laadi alla Toote omadused (SPC)
03-01-2023

Toimeaine:

Amoxicillin

Saadav alates:

Zoetis UK Limited

ATC kood:

QJ01CA04

INN (Rahvusvaheline Nimetus):

Amoxicillin

Ravimvorm:

Suspension for injection

Retsepti tüüp:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutiline rühm:

Cats, Dogs, Sheep

Terapeutiline ala:

Antimicrobial

Volitamisolek:

Authorized

Loa andmise kuupäev:

1998-01-28

Toote omadused

                                Revised: April 2022
AN: 01524/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Clamoxyl Long Acting 150 mg/ml Suspension for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active ingredients:_
_mg/ml_
Amoxicillin
150
(As Amoxicillin trihydrate)
For a full list of excipients please see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection.
White to off-white oily suspension.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep, dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is a broad-spectrum semi-synthetic penicillin which is
bactericidal _in _
_vitro_ against a wide range of Gram-positive and Gram-negative
bacteria including
the following:
_Gram-negative: _
_Actinobacillus lignieresi; Bordetella bronchiseptica, Escherichia
coli _(non beta-
lactamase
producing
strains)_, _
Corynebacterium
spp.;
Fusobacterium
spp.;
Haemophilus spp.; Moraxella spp.; Pasteurella spp.; _Proteus mirabilis
_(non beta-
lactamase producing strains);_ _Salmonella spp.
_Gram-positive:_
_Bacillus anthracis; _Clostridium spp_.; Erysipelothrix rhusiopathiae;
_Streptococci;
Staphylococci (non beta-lactamase producing strains).
The product is suitable for the control of infections caused by
susceptible
organisms in sheep, dogs and cats where prolonged activity from a
single
injection is required. It may also be used to control secondary
bacterial invasion
in conditions where bacteria are not a primary cause of disease.
Revised: April 2022
AN: 01524/2021
Page 2 of 6
Particular indications for the product are:
1.
Alimentary tract infections, including enteritis
2.
Respiratory tract infections.
3.
Urogenital tract infections, including cystitis and metritis
4.
Skin and soft tissue infections, including wounds, abscesses, foot
infections, joint and navel ill.
5.
Prevention of post-operative infections by injection prior to surgery.
4.3 CONTRA-INDICATIONS
In common with all other penicillins, amoxicillin should not be used
orally or
parenterally in rabbits, g
                                
                                Lugege kogu dokumenti
                                
                            

Otsige selle tootega seotud teateid